Skip to main content

5 Result(s)

within Margarita Reboredo Remove this filter Oncology Remove this filter

and

  1. Article

    Open Access

    Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study

    Treatment with nab-paclitaxel plus gemcitabine increases survival in patients with metastatic pancreatic cancer. However, the assessment of treatment efficacy and safety in non-selected patients in a real-life...

    Ana Fernández, Mercedes Salgado, Adelaida García, Elvira Buxò, Ruth Vera… in BMC Cancer (2018)

    Download PDF (1596 KB) View Article

  2. No Access

    Article

    Incidence of hand–foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen

    Hand–foot syndrome (HFS) is a limiting toxicity of capecitabine, which is not life-threatening but could compromise capecitabine efficacy.

    Carlos Gómez-Martin, Antonio Sánchez… in Clinical and Translational Oncology (2012)

  3. No Access

    Article

    A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)

    Purpose To determine the efficacy of the addition of gefitinib to raltitrexed in patients with colorectal cancer (CRC) that have progressed after first line chemotherapy. The study also sought to explore the safe...

    José María Viéitez, Manuel Valladares, Ignacio Peláez… in Investigational New Drugs (2011)

  4. No Access

    Article

    Locally advanced breast cancer: pulmonary toxicity secondary to gemcitabine

    Gemcitabine is indicated for the treatment of nonmicrocytic lung, breast, pancreatic, bladder and ovarian cancer. Mild dyspnea has been reported but the incidence of severe lung damage is low. We report the ca...

    Silvia Antolín, Lourdes Calvo, Diana Dopico… in Clinical and Translational Oncology (2010)

  5. No Access

    Article

    Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: a pilot study

    Detection of isolated tumour cells (ITC) in the blood or minimal deposits in distant organs such as bone marrow (BM) could be important to identify breast cancer patients at high risk of relapse or disease pro...

    Manuel Valladares-Ayerbes… in Journal of Cancer Research and Clinical On… (2009)